Healthcare Private Equity Market Hits Record Fundraising While Returns Lag Broader PE Sector

Healthcare private equity firms raised $16.2 billion in the first half of 2026, achieving record share of global private equity capital at 6.1%, though concentrated among fewer mega-funds. Returns from specialist healthcare PE funds have declined relative to the broader private equity market, with 2021-2023 vintages posting 10.2% IRR compared to 12.0% across all PE investments. Healthcare venture capital showed stronger momentum, rebounding to $4.7 billion in commitments with healthtech vehicles emerging from a prolonged funding trough.

The healthcare private equity sector is experiencing a structural transformation characterized by fewer, larger investment vehicles capturing an increasingly dominant share of available capital. Just 11 fund closings in the first half of 2026 generated nearly the entire prior year's fundraising total, with average fund sizes nearly doubling compared to 2025 levels. This consolidation reflects institutional investors' preference for established managers with proven operational capabilities and cross-border deal sourcing networks.

The performance divergence between healthcare private equity and venture capital suggests shifting risk-return expectations across the sector. While specialist healthcare PE funds are underperforming the broader PE market, healthtech venture vehicles are outpacing their general venture counterparts, indicating that capital allocation patterns are responding to demonstrable performance gaps and subsector-specific dynamics rather than maintaining historical allocation preferences.